We are live on ! Find out more
RA

Resolute Advisors Portfolio holdings

AUM $242M
1-Year Est. Return 52.95%
This Fund
S&P 500
This Quarter Est. Return
-54.59%
1 Year Est. Return
+52.95%
3 Year Est. Return
+38.33%
5 Year Est. Return
-44.39%
10 Year Est. Return
AUM
$963M
AUM Growth
-$1.4B
Cap. Flow
-$10.4M
Cap. Flow %
-1.08%
Top 10 Hldgs %
96.39%
Holding
139
New
7
Increased
24
Reduced
15
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 89.54%
2 Communication Services 1.22%
3 Consumer Discretionary 0.29%
4 Healthcare 0.11%
5 Consumer Staples 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOCN icon
51
DigitalOcean
DOCN
$12.4B
$143K 0.01%
3,460
+824
+31% +$36.8K
CHGG icon
52
Chegg
CHGG
$91.4M
$133K 0.01%
7,100
NXDR
53
Nextdoor Holdings
NXDR
$912M
$132K 0.01%
+40,000
New +$157K
VT icon
54
Vanguard Total World Stock ETF
VT
$76.6B
$131K 0.01%
1,539
+11
+0.7% +$1.02K
WEAV icon
55
Weave Communications
WEAV
$575M
$122K 0.01%
+40,000
New +$192K
PM icon
56
Philip Morris
PM
$301B
$115K 0.01%
1,154
+14
+1% +$1.43K
RQI icon
57
Cohen & Steers Quality Income Realty Fund
RQI
$1.67B
$113K 0.01%
8,304
+127
+2% +$1.86K
AFRM icon
58
Affirm
AFRM
$25.5B
$109K 0.01%
6,041
SOFI icon
59
SoFi Technologies
SOFI
$22.2B
$104K 0.01%
19,827
DNP icon
60
DNP Select Income Fund
DNP
$4.17B
$81K 0.01%
7,472
+128
+2% +$1.44K
META icon
61
Meta Platforms (Facebook)
META
$1.64T
$79K 0.01%
489
RXRX icon
62
Recursion Pharmaceuticals
RXRX
$1.56B
$75K 0.01%
9,168
FDMT icon
63
4D Molecular Therapeutics
FDMT
$575M
$67K 0.01%
9,600
AMPL icon
64
Amplitude
AMPL
$1.27B
$66K 0.01%
4,647
HAP icon
65
VanEck Natural Resources ETF
HAP
$303M
$59K 0.01%
1,293
EMBK
66
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$51K 0.01%
+5,000
New +$292K
ZY
67
DELISTED
Zymergen Inc. Common Stock
ZY
$49K 0.01%
+40,000
New +$67.1K
LYFT icon
68
Lyft
LYFT
$5.89B
$46K ﹤0.01%
3,467
EH
69
EHang Holdings
EH
$388M
$44K ﹤0.01%
4,800
RKT icon
70
Rocket Companies
RKT
$41.1B
$44K ﹤0.01%
6,000
HIMS icon
71
Hims & Hers Health
HIMS
$7.6B
$42K ﹤0.01%
9,289
LHDX
72
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$42K ﹤0.01%
22,800
DBX icon
73
Dropbox
DBX
$7.14B
$41K ﹤0.01%
1,934
BIDU icon
74
Baidu
BIDU
$36.5B
$39K ﹤0.01%
260
BTI icon
75
British American Tobacco
BTI
$136B
$30K ﹤0.01%
700

Similar funds

Resolute Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Resolute Advisors held 139 positions worth $963M, down 59% from $2.36B the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Resolute Advisors's Q2 2022 filing shows 7 new, 24 increased, 15 reduced and 8 closed positions. Its largest new stake was Aurora: 508,680 shares worth $972K. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $3.72M.

By sector, the portfolio is most concentrated in Technology at 90% of assets, down from 94% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Resolute Advisors's largest Q2 2022 buy was Aurora: 508,680 shares worth $972K.
  • Resolute Advisors added most to AbCellera Biologics in Q2 2022, an estimated $119K increase.
  • Resolute Advisors's biggest Q2 2022 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $3.72M.
  • Resolute Advisors fully exited State Street SPDR S&P Biotech ETF in Q2 2022, selling an estimated $888K.
  • Resolute Advisors's ten largest holdings make up 96% of its $963M portfolio in Q2 2022.
  • Resolute Advisors opened 7 new positions and closed 8 in Q2 2022.
  • Resolute Advisors's portfolio value fell 59% quarter-over-quarter to $963M.

Based on Resolute Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.